Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.27 (
thermolysin
)
1,894
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
P-selectin
on platelets and endothelial cells and E-selectin on endothelial cells are leukocyte receptors that recognize lineage-specific carbohydrates on neutrophils and monocytes. The proposed ligands for these receptors contain the Le(x) core and sialic acid. Since other investigators have shown that both E-selectin and
P-selectin
bind to sialylated Le(x), we evaluated whether E-selectin and
P-selectin
recognize the same counter-receptor on leukocytes. The interaction of HL60 cells with Chinese hamster ovary (CHO) cells expressing
P-selectin
or E-selectin was studied. To determine whether a protein component is required in addition to sialyl Le(x) for either
P-selectin
or E-selectin recognition, HL60 cells or neutrophils were digested with proteases, including chymotrypsin, elastase, proteinase Glu-C, ficin, papain, or
thermolysin
. Cells treated with these proteases bound E-selectin but not
P-selectin
. Fucosidase or neuraminidase treatment of HL60 cells markedly decreased binding to both E-selectin- and
P-selectin
-expressing CHO cells. Growth of HL60 cells in tunicamycin inhibited the ability of these cells to support
P-selectin
-mediated binding and, to a lesser extent, E-selectin-mediated binding. Purified
P-selectin
inhibited CHO:
P-selectin
binding to HL60 cells, but incompletely inhibited CHO:E-selectin binding to HL60 cells. However, purified soluble E-selectin inhibited CHO:
P-selectin
and CHO:E-selectin binding to HL60 cells equivalently and completely. COS cells, unable to bind to E-selectin or
P-selectin
, bound E-selectin but not
P-selectin
upon transfection with alpha-1,3-fucosyltransferase or alpha-1,3/1,4-fucosyltransferase. Similarly, LEC 11 cells expressing sialyl Le(x) bound E-selectin- but not
P-selectin
-expressing CHO cells. Sambucus nigra lectin, specific for the sialyl-2,6 beta Gal/GalNAc linkage, inhibited
P-selectin
but not E-selectin binding to HL60 cells. Although sialic acid and Le(x) are components of the
P-selectin
ligand and the E-selectin ligand, these results indicate that the ligands are related, having overlapping specificities, but are structurally distinct. A protein component containing sialyl Le(x) in proximity to sialyl-2,6 beta Gal structures on the
P-selectin
ligand may contribute to its specificity for
P-selectin
.
...
PMID:P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities. 137 36
P-selectin
overexpressed on activated endothelial cells and platelets is a new target for treatment of cancers and cardiovascular diseases such as atherosclerosis and thrombosis. In this study, depolymerized low molecular weight fucoidan (LMWF
8775
) and a
thermolysin
-hydrolyzed protamine peptide (TPP
1880
) were prepared. TPP
1880
and LMWF
8775
were able to form self-assembled complex nanoparticles (CNPs). The formation of TPP
1880
/LMWF
8775
CNPs was characterized by Fourier-transform infrared spectra, circular dichroism spectra and isothermal titration calorimetry. The CNPs selectively targeted PMA-stimulated, inflamed endothelial cells (HUVECs) with high expression of
P-selectin
. Gd-DTPA MRI contrast agent was successfully loaded in the CNPs with better T
1
relaxivity and selectively accumulated in the activated HUVECs with increased MRI intensity and reduced cytotoxicity as compared to free Gd-DTPA. Our results suggest that the TPP
1880
/LMWF
8775
CNPs may have potential in future for early diagnosis of cardiovascular diseases and cancers in which the endothelium is inflamed or activated.
...
PMID:Synthesis and characterization of Gd-DTPA/fucoidan/peptide complex nanoparticle and in vitro magnetic resonance imaging of inflamed endothelial cells. 3299 13